The settlement of the patent infringement suit captioned “Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,” remains subject to review by the U.S. Federal Trade Commission.
In…
A trial date has been set for April 5, 2010, on Forest Laboratories Inc.’s patent infringement complaint against generic manufacturers of Namenda, the Company’s N-methyl-D-aspartate.
During the third quarter of fiscal…
A trial on the patent infringement action captioned Infosint S.A. v. H. Lundbeck A/S, H. Lundbeck Inc. and Forest Laboratories, Inc., is scheduled to begin on Sept. 28, 2009.
In April…
Discovery is scheduled to continue in Forest Laboratories Inc.’s suit against Caraco Pharmaceutical Laboratories Ltd. for the alleged infringement of U.S. Patent No. Re. 24,712 in the U.S. District Court…